Multi-omics studies from AD mouse models and postmortem brain tissue showed concordant changes among chromatin states, DNA accessibility, transcriptomics [48, 79], and widespread loss of CpH methylation at enhancers of AD neurons significantly converge on transcriptomic changes related to abnormal CCR, apoptotic and inflammatory pathways [67]. The gene discussed is CPE; the disease is Alzheimer disease.